Spots Global Cancer Trial Database for Gadobutrol Magnevist-controlled Body Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Gadobutrol Magnevist-controlled Body Study
Official Title: A Multi-center/Multi-national, Randomized, Controlled, Single-blind, Group Comparison Phase 3 Study to Determine the Efficacy and Safety of Gadobutrol 1.0 Molar in Comparison to Magnevist Following Single Injection in Patients Referred for Contrast-enhanced MRI of the Body/Extremities Regions (Breast, Heart, Abdomen, Kidney, Pelvis, or Extremities)
Study ID: NCT01050829
Conditions
Study Description
Brief Summary: The purpose of the study is to look at the safety (what are the side effects) and efficacy (how well does it work) of gadobutrol when used for taking MR images of the body/extremities regions. The results of the MRI with gadobutrol injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with Magnevist.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Nanjing, Jiangsu, China
, Suzhou, Jiangsu, China
, Xi'an, Shanxi, China
, Beijing, , China
, Shanghai, , China
, Shanghai, , China
, Kamogawa, Chiba, Japan
, Matsuyama, Ehime, Japan
, Chikushino, Fukuoka, Japan
, Kobe, Hyogo, Japan
, Sunto, Shizuoka, Japan
, Bunkyo-ku, Tokyo, Japan
, Fukuoka, , Japan
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
Contact Details
Name: Bayer Study Director
Affiliation: Bayer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
